1. Home
  2. TCI vs LUNG Comparison

TCI vs LUNG Comparison

Compare TCI & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transcontinental Realty Investors Inc.

TCI

Transcontinental Realty Investors Inc.

N/A

Current Price

$50.00

Market Cap

380.3M

Sector

Finance

ML Signal

N/A

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$2.54

Market Cap

63.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCI
LUNG
Founded
1983
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
380.3M
63.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
TCI
LUNG
Price
$50.00
$2.54
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$6.81
AVG Volume (30 Days)
1.8K
1.1M
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
75.87
N/A
EPS
0.65
N/A
Revenue
$48,675,000.00
$91,664,000.00
Revenue This Year
N/A
$9.21
Revenue Next Year
N/A
$5.03
P/E Ratio
$76.80
N/A
Revenue Growth
N/A
15.59
52 Week Low
$25.50
$1.31
52 Week High
$51.71
$9.37

Technical Indicators

Market Signals
Indicator
TCI
LUNG
Relative Strength Index (RSI) 61.54 71.32
Support Level $43.01 $1.96
Resistance Level $48.00 $1.74
Average True Range (ATR) 0.92 0.20
MACD 0.25 0.10
Stochastic Oscillator 90.00 91.13

Price Performance

Historical Comparison
TCI
LUNG

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: